Efficacy evaluation of adalimumab (HUMIRA (R)) by dose and administration route of concomitant methotrexate in widespread clinical practice (react trial)
Αποθετήριο DSpace/Manakin
JavaScript is disabled for your browser. Some features of this site may not work without it.
Efficacy evaluation of adalimumab (HUMIRA (R)) by dose and administration route of concomitant methotrexate in widespread clinical practice (react trial)